- Estimated combined risk-based capital ("RBC") ratio between 430% and 450%; holding company liquid assets of
$0.9 billion - Annuity sales of
$2.4 billion , primarily driven by$2.1 billion in sales of Shield Level Annuities - Life sales of
$39 million , primarily driven by sales of SmartCare - Net income available to shareholders of
$956 million , or$16.53 per diluted share - Adjusted earnings* of
$258 million , or$4.45 per diluted share
Second Quarter 2026 Results
The company reported net income available to shareholders of
The company ended the second quarter of 2026 with common stockholders' equity ("book value") of
For the second quarter of 2026, the company reported adjusted earnings* of
Corporate expenses in the second quarter of 2026 were
_________ |
* Information regarding the non-GAAP and other financial measures included in this news release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP measures are provided in the Non-GAAP and Other Financial Disclosures discussion below, as well as in the tables that accompany this news release and/or the Second Quarter 2026 |
In the second quarter of 2026, the company reported annuity sales of
Key Metrics (Unaudited, dollars in millions except share and per share amounts) | ||||||||
|
| As of or For the Three Months Ended | ||||||
|
|
| ||||||
|
| Total |
| Per share |
| Total |
| Per share |
Net income (loss) available to shareholders (1) |
|
|
|
| ||||
Adjusted earnings (1) |
|
|
|
| ||||
Adjusted earnings, less notable items (1) |
|
|
|
| ||||
Weighted average common shares outstanding - diluted (1) |
| 57,840,353 |
| N/A |
| 57,734,170 |
| N/A |
|
|
|
|
|
|
|
|
|
Book value |
|
|
|
| ||||
Book value, excluding AOCI |
|
|
|
| ||||
Ending common shares outstanding |
| 57,508,193 |
| N/A |
| 57,122,494 |
| N/A |
|
|
|
|
|
|
|
|
|
(1) Per share amounts are on a diluted basis and may not recalculate due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||||
Results by Segment (Unaudited, in millions) | ||||||
|
| For the Three Months Ended | ||||
ADJUSTED EARNINGS (LOSS) (1) |
|
|
|
|
|
|
Annuities |
|
|
| |||
Life |
|
|
| |||
Run-off |
|
|
| |||
Corporate & Other |
|
|
| |||
(1) The company uses the term "adjusted loss" throughout this news release to refer to negative adjusted earnings values. | ||||||
Sales (Unaudited, in millions) | ||||||
|
| For the Three Months Ended | ||||
|
|
|
|
|
|
|
Annuities (1) |
|
|
| |||
Life |
|
|
| |||
|
|
|
|
|
|
|
(1) Annuities sales include sales of a fixed index annuity product, which represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Sales of this product were | ||||||
Annuities
Adjusted earnings in the Annuities segment were
There were no notable items in the current quarter or the comparison quarters.
On a quarter-over-quarter basis, adjusted earnings reflect higher net investment income, partially offset by lower income annuity underwriting margin, and higher DAC amortization. On a sequential basis, adjusted earnings primarily reflect lower expenses and higher net investment income.
As mentioned above, the company reported annuity sales of
Life
The Life segment had an adjusted loss of
There were no notable items in the current quarter or in the second quarter of 2025. The first quarter of 2026 included a
Both on a quarter-over-quarter and sequential basis, the adjusted loss, less notable items, reflects a higher underwriting margin, partially offset by lower net investment income.
As mentioned above, the company reported Life sales of
Run-off
The Run-off segment had an adjusted loss of
There were no notable items in the current quarter or the second quarter of 2025. The first quarter of 2026 included a
On a quarter-over-quarter basis, the adjusted loss reflects a higher underwriting margin and lower expenses, partially offset by lower net investment income. On a sequential basis, the adjusted loss, less notable items, reflects lower net investment income, partially offset by lower expenses.
Corporate & Other
The Corporate & Other segment had an adjusted loss of
There were no notable items in the current quarter or the comparison quarters.
On a quarter-over-quarter basis, the adjusted loss reflects lower net investment income, partially offset by higher interest credited. On a sequential basis, the adjusted loss was flat.
Net Investment Income and Adjusted Net Investment Income (Unaudited, in millions) | ||||||
|
| For the Three Months Ended | ||||
|
|
|
|
|
|
|
Net investment income |
|
|
| |||
Adjusted net investment income |
|
|
| |||
Net Investment Income
Net investment income was
Adjusted net investment income decreased
The adjusted net investment income yield* was 4.17% during the quarter.
|
| As of | ||||
|
|
|
|
|
|
|
Statutory combined total adjusted capital |
|
|
| |||
|
|
|
|
|
|
|
(1) Reflects preliminary statutory results as of | ||||||
Capitalization
As of
- Statutory combined total adjusted capital(1) was
$4.9 billion , relatively flat fromMarch 31, 2026 - Estimated combined RBC ratio(1) was between 430% and 450%, consistent with the first quarter of 2026 and at the upper end of our target combined RBC range of 400% to 450% in normal markets
- Holding company liquid assets were
$0.9 billion
_______________ |
(1) Reflects preliminary statutory results as of |
Pending Merger with
On
The completion of the merger remains subject to receipt of insurance regulatory approvals in
About
(1) Ranked by 2025 admitted assets. Best's Review®: Top 200 U.S. Life/Health Insurers. AM Best, 2026. |
Note Regarding Forward-Looking Statements
This news release and other oral or written statements that
Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of
For the reasons described above,
The information contained on or connected to any websites referenced in this news release is not incorporated by reference into this news release.
Non-GAAP and Other Financial Disclosures
Our definitions of non-GAAP and other financial measures may differ from those used by other companies.
Non-GAAP Financial Disclosures
We present certain measures of our performance that are not calculated in accordance with accounting principles generally accepted in
The following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:
Non-GAAP financial measures: | Most directly comparable GAAP financial measures: |
adjusted earnings | net income (loss) available to shareholders (1) |
adjusted earnings, less notable items | net income (loss) available to shareholders (1) |
adjusted revenues | revenues |
adjusted expenses | expenses |
adjusted earnings per common share | earnings per common share, diluted (1) |
adjusted earnings per common share, less notable items | earnings per common share, diluted (1) |
adjusted return on common equity | return on common equity (2) |
adjusted net investment income | net investment income |
adjusted net investment income yield | net investment income yield |
__________________ |
|
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to | |
(2) Brighthouse uses return on common equity to refer to return on | |
Reconciliations to the most directly comparable historical GAAP measures are included for those measures which are presented herein. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are not accessible on a forward-looking basis because we believe it is not possible without unreasonable efforts to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income (loss) available to shareholders.
Adjusted Earnings, Adjusted Revenues and Adjusted Expenses
Adjusted earnings is a financial measure used by management to evaluate performance and facilitate comparisons to industry results. This financial measure, which may be positive or negative, focuses on our primary businesses by excluding the impact of market volatility, which could distort trends.
Adjusted earnings reflect adjusted revenues less (i) adjusted expenses, (ii) provision for income tax expense (benefit), (iii) net income (loss) attributable to noncontrolling interests and (iv) preferred stock dividends. Provided below are the adjustments to GAAP revenues and GAAP expenses used to calculate adjusted revenues and adjusted expenses, respectively.
The following items are excluded from total revenues in calculating the adjusted revenues component of adjusted earnings:
- Net investment gains (losses);
- Investment gains (losses) on trading securities measured at estimated fair value through net investment income; and
- Net derivative gains (losses) ("NDGL"), excluding earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment ("Investment Hedge Adjustments").
The following items are excluded from total expenses in calculating the adjusted expenses component of adjusted earnings:
- Change in market risk benefits; and
- Change in fair value of the crediting rate on experience-rated contracts and market value adjustments on institutional group annuities that are economically offset by gains (losses) on the related trading securities ("Market Value Adjustments").
The provision for income tax related to adjusted earnings is calculated using the statutory tax rate of 21%, net of impacts related to the dividends received deduction, tax credits and current period non-recurring items.
Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance.
Adjusted Earnings per Common Share and Adjusted Return on Common Equity
Adjusted earnings per common share and adjusted return on common equity are measures used by management to evaluate the execution of our business strategy and align such strategy with our shareholders' interests.
Adjusted earnings per common share is defined as adjusted earnings for the period divided by the weighted average number of fully diluted shares of common stock outstanding for the period. The weighted average common shares outstanding used to calculate adjusted earnings per share will differ from such shares used to calculate diluted net income (loss) available to shareholders per common share when the inclusion of dilutive shares has an anti-dilutive effect for one calculation but not for the other.
Adjusted return on common equity is defined as total annual adjusted earnings on a four quarter trailing basis, divided by the simple average of the most recent five quarters of total
Adjusted Net Investment Income
Adjusted net investment income is used by management to measure our performance, and we believe it enhances the understanding of our investment portfolio results. Adjusted net investment income represents GAAP net investment income plus Investment Hedge Adjustments less investment gains (losses) on trading securities.
Adjusted Net Investment Income Yield
Similar to adjusted net investment income, adjusted net investment income yield is used by management as a performance measure that we believe enhances the understanding of our investment portfolio results. Adjusted net investment income yield represents adjusted net investment income as a percentage of average quarterly asset carrying values. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. Investment fee and expense yields are calculated as a percentage of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties.
Other Financial Disclosures
Corporate Expenses
Corporate expenses includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation.
Notable Items
Certain of the non-GAAP measures described above may be presented further adjusted to exclude notable items. Notable items reflect the unfavorable (favorable) after-tax impact on our results of certain unanticipated items and events, as well as certain items and events that were anticipated. The presentation of notable items and non-GAAP measures, less notable items is intended to help investors better understand our results and to evaluate and forecast those results.
Book Value per Common Share and Book Value per Common Share, excluding AOCI
Brighthouse uses the term "book value" to refer to "
Holding Company
Holding company means, collectively,
Holding Company Liquid Assets
Holding company liquid assets include liquid assets in
Total adjusted capital primarily consists of statutory capital and surplus, as well as the statutory asset valuation reserve. When referred to as “combined,” represents that of our insurance subsidiaries as a whole.
Sales
Life insurance sales consist of 100 percent of annualized new premium for term life, first-year paid premium for whole life, universal life, and variable universal life, and total paid premium for indexed universal life. We exclude company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life.
Annuity sales consist of 100 percent of direct statutory premiums, except for fixed index annuity sales, which represents 100 percent of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Annuity sales exclude certain internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.
Risk-Based Capital Ratio
The risk-based capital ratio is a method of measuring an insurance company’s capital, taking into consideration its relative size and risk profile, in order to ensure compliance with minimum regulatory capital requirements set by the
Condensed Statements of Operations (Unaudited, in millions) | ||||||
|
| For the Three Months Ended | ||||
Revenues |
|
|
|
|
|
|
Premiums |
|
|
| |||
Universal life and investment-type product policy fees |
| 570 |
| 533 |
| 553 |
Net investment income |
| 1,241 |
| 1,258 |
| 1,285 |
Other revenues |
| 129 |
| 129 |
| 143 |
Revenues before NIGL and NDGL |
| 2,105 |
| 2,088 |
| 2,147 |
Net investment gains (losses) |
| (6) |
| (52) |
| (39) |
Net derivative gains (losses) |
| (477) |
| (509) |
| (1,237) |
Total revenues |
|
|
| |||
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
Policyholder benefits and claims |
|
|
| |||
Interest credited to policyholder account balances |
| 531 |
| 493 |
| 537 |
Amortization of DAC and VOBA |
| 157 |
| 158 |
| 149 |
Change in market risk benefits |
| (1,370) |
| 748 |
| (1,101) |
Interest expense on debt |
| 38 |
| 38 |
| 38 |
Other expenses |
| 449 |
| 439 |
| 444 |
Total expenses |
| 396 |
| 2,513 |
| 778 |
Income (loss) before provision for income tax |
| 1,226 |
| (986) |
| 93 |
Provision for income tax expense (benefit) |
| 245 |
| (222) |
| 8 |
Net income (loss) |
| 981 |
| (764) |
| 85 |
Less: Net income (loss) attributable to noncontrolling interests |
| — |
| 2 |
| — |
Net income (loss) attributable to |
| 981 |
| (766) |
| 85 |
Less: Preferred stock dividends |
| 25 |
| 26 |
| 25 |
Net income (loss) available to |
|
|
| |||
Condensed Balance Sheets (Unaudited, in millions) | ||||||
|
| As of | ||||
ASSETS |
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
Fixed maturity securities available-for-sale |
|
|
| |||
Trading securities |
| 596 |
| 544 |
| 520 |
Equity securities |
| 83 |
| 76 |
| 74 |
Mortgage loans |
| 22,607 |
| 22,620 |
| 22,993 |
Policy loans |
| 1,455 |
| 1,458 |
| 1,425 |
Limited partnerships and limited liability companies |
| 4,568 |
| 4,673 |
| 4,798 |
Short-term investments |
| 960 |
| 1,236 |
| 1,170 |
Other invested assets |
| 13,940 |
| 9,617 |
| 8,932 |
Total investments |
| 125,032 |
| 121,456 |
| 120,747 |
Cash and cash equivalents |
| 7,105 |
| 4,907 |
| 5,540 |
Accrued investment income |
| 1,235 |
| 1,302 |
| 1,235 |
Reinsurance recoverables |
| 20,064 |
| 20,313 |
| 20,701 |
Premiums and other receivables |
| 693 |
| 513 |
| 557 |
DAC and VOBA |
| 4,487 |
| 4,520 |
| 4,636 |
Current income tax recoverable |
| 10 |
| 16 |
| 17 |
Deferred income tax asset |
| 1,535 |
| 1,781 |
| 1,695 |
Market risk benefit assets |
| 1,025 |
| 850 |
| 1,084 |
Other assets |
| 303 |
| 324 |
| 348 |
Separate account assets |
| 85,691 |
| 80,821 |
| 86,085 |
Total assets |
|
|
| |||
LIABILITIES AND EQUITY |
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
Future policy benefits |
|
|
| |||
Policyholder account balances |
| 89,076 |
| 86,379 |
| 88,046 |
Market risk benefit liabilities |
| 7,439 |
| 8,564 |
| 8,051 |
Other policy-related balances |
| 3,836 |
| 3,994 |
| 3,977 |
Payables for collateral under securities loaned and other transactions |
| 6,781 |
| 4,661 |
| 3,994 |
Long-term debt |
| 3,154 |
| 3,154 |
| 3,155 |
Other liabilities |
| 12,648 |
| 11,829 |
| 11,625 |
Separate account liabilities |
| 85,691 |
| 80,821 |
| 86,085 |
Total liabilities |
| 240,565 |
| 231,175 |
| 236,907 |
Equity |
|
|
|
|
|
|
Preferred stock, at par value |
| — |
| — |
| — |
Common stock, at par value |
| 1 |
| 1 |
| 1 |
Additional paid-in capital |
| 13,847 |
| 13,869 |
| 13,918 |
Retained earnings (deficit) |
| (471) |
| (1,452) |
| (1,302) |
| (2,701) |
| (2,699) |
| (2,687) | |
Accumulated other comprehensive income (loss) |
| (4,126) |
| (4,156) |
| (4,257) |
Total |
| 6,550 |
| 5,563 |
| 5,673 |
Noncontrolling interests |
| 65 |
| 65 |
| 65 |
Total equity |
| 6,615 |
| 5,628 |
| 5,738 |
Total liabilities and equity |
|
|
| |||
Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings (Loss) and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings (Loss) per Common Share and Adjusted Earnings, Less Notable Items, per Common Share (Unaudited, in millions except per share data) | ||||||
|
| For the Three Months Ended | ||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS |
|
|
|
|
|
|
Net income (loss) available to shareholders |
|
|
| |||
Less: Net investment gains (losses) |
| (6) |
| (52) |
| (39) |
Less: Investment gains (losses) on trading securities |
| 2 |
| (10) |
| (6) |
Less: Net derivative gains (losses), excluding investment hedge adjustments |
| (477) |
| (509) |
| (1,238) |
Less: Change in market risk benefits |
| 1,370 |
| (748) |
| 1,101 |
Less: Market value adjustments |
| (4) |
| 13 |
| 6 |
Less: Provision for income tax (expense) benefit on reconciling adjustments |
| (187) |
| 275 |
| 38 |
Adjusted earnings (loss) |
| 258 |
| 239 |
| 198 |
Less: Notable items |
| — |
| (12) |
| — |
Adjusted earnings, less notable items |
|
|
| |||
|
|
|
|
|
|
|
ADJUSTED EARNINGS, LESS NOTABLE ITEMS, PER COMMON SHARE (1) |
|
|
|
|
|
|
Net income (loss) available to shareholders per common share |
|
|
| |||
Less: Net investment gains (losses) |
| (0.10) |
| (0.91) |
| (0.68) |
Less: Investment gains (losses) on trading securities |
| 0.03 |
| (0.17) |
| (0.10) |
Less: Net derivative gains (losses), excluding investment hedge adjustments |
| (8.25) |
| (8.88) |
| (21.44) |
Less: Change in market risk benefits |
| 23.69 |
| (13.05) |
| 19.07 |
Less: Market value adjustments |
| (0.07) |
| 0.23 |
| 0.10 |
Less: Provision for income tax (expense) benefit on reconciling adjustments |
| (3.23) |
| 4.80 |
| 0.66 |
Less: Impact of inclusion of dilutive shares |
| — |
| 0.03 |
| — |
Adjusted earnings (loss) per common share |
| 4.45 |
| 4.15 |
| 3.43 |
Less: Notable items |
| — |
| (0.21) |
| — |
Adjusted earnings, less notable items per common share |
|
|
| |||
|
|
|
|
|
|
|
(1) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||
Reconciliation of Net Investment Income to Adjusted Net Investment Income (Unaudited, in millions) | ||||||
|
| For the Three Months Ended | ||||
ADJUSTED NET INVESTMENT INCOME (1) |
|
|
|
|
|
|
Net investment income |
|
|
| |||
Add: Investment hedge adjustments |
| — |
| — |
| 1 |
Less: Investment gains (losses) on trading securities |
| 2 |
| (10) |
| (6) |
Adjusted net investment income |
|
|
| |||
Reconciliation of Investment Income Yield to Adjusted Net Investment Income Yield | ||||||
|
| For the Three Months Ended | ||||
ADJUSTED NET INVESTMENT INCOME YIELD (1) |
|
|
|
|
|
|
Investment income yield |
| 4.32% |
| 4.39% |
| 4.41% |
Investment fees and expenses |
| (0.15)% |
| (0.15)% |
| (0.13)% |
Adjusted net investment income yield |
| 4.17% |
| 4.24% |
| 4.28% |
Notable Items (Unaudited, in millions) | ||||||
|
| For the Three Months Ended | ||||
NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS |
|
|
|
|
|
|
Actuarial items and other insurance adjustments |
| $— |
|
| $— | |
Total notable items (1) |
| $— |
|
| $— | |
|
|
|
|
|
|
|
NOTABLE ITEMS BY SEGMENT |
|
|
|
|
|
|
Annuities |
| $— |
| $— |
| $— |
Life |
| — |
| (5) |
| — |
Run-off |
| — |
| 17 |
| — |
Corporate & Other |
| — |
| — |
| — |
Total notable items (1) |
| $— |
|
| $— | |
| ||||||
(1) See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260805886329/en/
FOR INVESTORS
(980) 949-3073
damante@brighthousefinancial.com
FOR MEDIA
(980) 949-4142
mlantier@brighthousefinancial.com
Source: